Analyst price target range
Ernexa Therapeutics Price Target: $30.00 Average
ERNA target range is $30.00 to $30.00. As of 2026-08-24.
Direct answer
Ernexa Therapeutics's average price target is $30.00.
The verified analyst range runs from $30.00 to $30.00.
The low target implies +517.3%, the high target implies +517.3%, and the range spans 0% of the current price.
Forecast evidence checked August 24, 2026.
Get free Ernexa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.86
- Average price target
- $30.00
- High price target
- $30.00
- Low price target
- $30.00
- Low target gap
- +517.3%
- Target upside
- +517.3%
- High target gap
- +517.3%
- Target range width
- 0%
- Consensus rating
- Strong Buy
- Analysts
- 1
- Evidence date
- August 24, 2026
- Valid through
- August 31, 2026
Explore related company data
Read the frequently asked questions.
What is Ernexa Therapeutics's average price target?
Ernexa Therapeutics's verified average price target is $30.00. The target range is $30.00 to $30.00.
How far are Ernexa Therapeutics's low and high targets from the recorded price?
The low target implies +517.3%, while the high target implies +517.3%.
How many analysts are included in Ernexa Therapeutics's consensus?
The verified consensus includes 1 analysts.
How is Ernexa Therapeutics's target upside or downside calculated?
The average target of $30.00 is divided by the recorded price of $4.86, then one is subtracted to produce +517.3%. This does not guarantee a future return.
When was Ernexa Therapeutics's analyst forecast verified?
The data was verified on 2026-08-24. The dataset is valid through 2026-08-31.